New Product Scientifically Battles Aging at the Cellular Level

Exclusively licensed from the Geron Corporation, TA-65 is the world's first

Telomerase Activator

    NEW YORK, April 9 /PRNewswire/ -- Telomerase Activation Sciences, Inc.
 (TA Sciences) announced on March 12 its license with Geron to develop and
 market non-therapeutic products using Geron's small molecule telomerase
 activators. Now TA Sciences announces the opening of the TA Sciences Center
 in Manhattan where customers can purchase TA Sciences' first product, a
 nutraceutical containing the telomerase activating agent "TA-65."
     "TA Sciences welcomes our first customers and the launch of the world's
 first telomerase activator product," said Noel Thomas Patton, founder of TA
 Sciences. "A natural consequence of aging is the shortening of telomeres
 (caps of DNA located at the ends of all chromosomes), which ultimately
 results in loss of cell function. TA-65 offers the potential of reducing or
 reversing telomere shortening and battles tissue and organ degeneration by
 rejuvenating aging cells."
     TA-65 is the result of vigorous scientific research that began at Geron
 in 1992. Already the response from the scientific community to the news of
 TA Sciences' ground-breaking launch has been very enthusiastic: "Telomerase
 Activation is the single most promising approach to reversing the effects
 of aging," said Michael Fossel, MD, PhD., Clinical Professor of Medicine at
 Michigan State University, author, and recognized authority on aging and
 age- related clinical disease.
     And Dr. William H. Andrews, founder of Sierra Sciences, LLC and one of
 the principal discoverers of the telomerase genes, said: "Cleopatra, Ponce
 de Leon, and untold others throughout the ages have searched for the
 secrets of youth. That search has been futile, until now: Telomerase
 Activation is the first and only scientifically sound way to approach anti-
 aging. TA-65 is the first product in history that has been proven to slow
 or reverse cellular aging. Congratulations to TA Sciences and Geron!"
     On April 30, 2007 TA Sciences plans to publish the results of the
 Pivotal 2005 Anti-Aging Trial, which is the first ever human clinical trial
 of a telomerase activator. This trial shows statistical verification of the
 anti- aging benefits of telomerase activation.
     About TA Sciences:
     The TA Sciences Center is located at 24 E. 64th Street in New York. The
 company offers its telomerase-activating products as part of the 12 month
 "Patton Protocol." The driver of TA Sciences' product line is the
 telomerase- activating small molecule "TA-65," sold under license from
 Geron. For more information on TA Sciences visit http://www.TASciences.com
 or call 888-360-8886. For more information on Geron visit
 http://www.Geron.com.
 
 

SOURCE TA Sciences Inc.